1,597 hedge funds and large institutions have $95.7B invested in Amgen in 2017 Q1 according to their latest regulatory filings, with 151 funds opening new positions, 680 increasing their positions, 576 reducing their positions, and 71 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

4% more funds holding

Funds holding: 1,5381,597 (+59)

1.05% more ownership

Funds ownership: 78.09%79.15% (+1.1%)

33% less call options, than puts

Call options by funds: $1.14B | Put options by funds: $1.7B

Holders
1,597
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
79
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.14B
Puts
$1.7B
Net Calls
Net Calls Change

Top Buyers

1 +$7.72B
2 +$2.26B
3 +$592M
4
Barclays
Barclays
United Kingdom
+$248M
5
Goldman Sachs
Goldman Sachs
New York
+$164M

Top Sellers

1 -$1.36B
2 -$392M
3 -$151M
4
Primecap Management
Primecap Management
California
-$148M
5
O
OrbiMed
New York
-$148M
Name Holding Trade Value Shares
Change
Change in
Stake
1176
$565K
1177
$562K
1178
$560K
1179
$559K
1180
$558K
1181
$558K
1182
$555K
1183
$554K
1184
$554K
1185
$552K
1186
$551K
1187
$551K
1188
$550K
1189
$550K
1190
$548K
1191
$544K
1192
$541K
1193
$536K
1194
$536K
1195
$535K
1196
$535K
1197
$534K
1198
$533K
1199
$533K
1200
$533K